Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases

Explore clinical trials studying Genital Diseases. Study availability and eligibility vary by location and protocol.

21,651 public trials 3,214 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases trial results

Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

NCT07393659

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Durban, KwaZulu-Natal, South Africa
  • GSK Investigational Site Jouberton, Matlosana, South Africa
  • GSK Investigational Site Gauteng, South Africa
  • GSK Investigational Site Johannesburg, South Africa
View Trial Details
Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

NCT07028853

Conditions
Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Gilbert, Arizona, United States
View all 337 locations
View Trial Details
Recruiting

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

NCT07650916

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 88 locations
View Trial Details

Related conditions